» Articles » PMID: 9741311

Serum Androgen-anabolic Hormones and the Risk of Rheumatoid Arthritis

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 1998 Sep 19
PMID 9741311
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: It has been hypothesised, mainly on the basis of indirect evidence, that low serum concentrations of androgen-anabolic hormones would play a causal part in the aetiology of rheumatoid arthritis (RA).

Methods: A case-control study was nested with a Finnish cohort of 19,072 adults who had neither arthritis nor a history of it at the baseline examination during 1973-1977. Pre-illness serum specimens for the assay of testosterone and dehydroepiandrosterone sulphate (DHEAS) were available from 116 cases who had developed RA by late 1989. Three controls per each incident case were individually matched for sex, age, and municipality.

Results: The mean testosterone concentration was 1.4 nmol/l in those 84 women who developed RA and 1.4 nmol/l in their controls; the corresponding figures for DHEAS were 5.2 mumol/l and 5.5 mumol/l, respectively. Mean testosterone concentration in the 32 male cases was 26.1 nmol/l and 26.4 nmol/l in their controls; the corresponding figures for DHEAS were 11.2 mumol/l and 10.1 mumol/l, respectively. Analysis by subgroups (rheumatoid factor positive and negative disease, pre-menopausal and postmenopausal women) and by hormone distributions showed no differences.

Conclusion: The findings are not in line with the contention that low concentrations of testosterone and DHEAS play a part in the aetiology of RA.

Citing Articles

Sex steroids and autoimmune rheumatic diseases: state of the art.

Cutolo M, Straub R Nat Rev Rheumatol. 2020; 16(11):628-644.

PMID: 33009519 DOI: 10.1038/s41584-020-0503-4.


Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort Study.

Klil-Drori A, Santella C, Tascilar K, Yin H, Aprikian A, Azoulay L Drug Saf. 2019; 42(8):1005-1011.

PMID: 31240687 DOI: 10.1007/s40264-019-00847-w.


Androgen-Induced Immunosuppression.

Gubbels Bupp M, Jorgensen T Front Immunol. 2018; 9:794.

PMID: 29755457 PMC: 5932344. DOI: 10.3389/fimmu.2018.00794.


Contribution of Genetic Factors to Lower DHEAS in Patients with Rheumatoid Arthritis.

Vernerova L, Mravcova M, Paulikova L, Vlcek M, Marko A, Meskova M Cell Mol Neurobiol. 2017; 38(1):379-383.

PMID: 28712091 PMC: 11481829. DOI: 10.1007/s10571-017-0522-0.


Environmental factors and hormones in the development of rheumatoid arthritis.

Alpizar-Rodriguez D, Finckh A Semin Immunopathol. 2017; 39(4):461-468.

PMID: 28451785 DOI: 10.1007/s00281-017-0624-2.


References
1.
Dai W, Kuller L, LaPorte R, Gutai J, Caggiula A . The epidemiology of plasma testosterone levels in middle-aged men. Am J Epidemiol. 1981; 114(6):804-16. DOI: 10.1093/oxfordjournals.aje.a113251. View

2.
Aho K, Heliovaara M, Knekt P, Reunanen A, Aromaa A, Leino A . Serum immunoglobulins and the risk of rheumatoid arthritis. Ann Rheum Dis. 1997; 56(6):351-6. PMC: 1752401. DOI: 10.1136/ard.56.6.351. View

3.
Cutolo M, Balleari E, Accardo S, Samanta E, Cimmino M, Giusti M . Preliminary results of serum androgen level testing in men with rheumatoid arthritis. Arthritis Rheum. 1984; 27(8):958-9. DOI: 10.1002/art.1780270821. View

4.
Rotter J, Wong F, Lifrak E, Parker L . A genetic component to the variation of dehydroepiandrosterone sulfate. Metabolism. 1985; 34(8):731-6. DOI: 10.1016/0026-0495(85)90023-x. View

5.
Couwenbergs C, Knussmann R, Christiansen K . Comparisons of the intra- and inter-individual variability in sex hormone levels of men. Ann Hum Biol. 1986; 13(1):63-72. DOI: 10.1080/03014468600008201. View